The respiratory microbiome in patients with post-COVID-19 residual lung abnormalities resembles that of healthy individuals and is distinct from idiopathic pulmonary fibrosis.

When species evenness was also considered using the Shannon diversity index, the post-COVID-19 cohort exhibited lower diversity compared to control subjects and ILD patients, although these differences did not reach statistical significance ( figure 3a ).

also in 111,027 other papers